PlexusDx Review

PlexusDx: a genetics-flavored GLP-1 program with a low entry price

PlexusDx pitches itself differently from the typical compounded-GLP-1 shop. Its homepage leads with the line "Built around your genetics," and the company pairs a standard prescription weight-loss program with an optional DNA panel it calls Precision Peptide. Strip away the genetics angle, though, and the core offer is familiar: compounded semaglutide and tirzepatide prescribed by a licensed clinician and shipped to your door. The thing that actually makes PlexusDx worth a look for most people isn't the genetics — it's that the entry-level dose starts well below the category median, at $129 a month.

If you want a no-insurance, all-inclusive program and you're price-sensitive, PlexusDx is competitive. If you're hoping the genetic test will meaningfully change your dosing, temper your expectations — more on that below.

How the pricing actually works: a four-rung ladder

PlexusDx doesn't sell one product at one price. It offers four tiers, each labeled "All-Inclusive," meaning the quoted monthly figure bundles the medication and the clinician review together rather than billing a separate consult fee on top:

• Microdose GLP-1 — the cheapest way in at $129 a month, a low-dose compounded semaglutide program aimed at people easing into GLP-1s or maintaining results.
• Compounded semaglutide — the standard weight-loss tier, starting in the mid-one-hundreds per month.
• Compounded tirzepatide — the dual-action option, starting at a higher figure in the mid-two-hundreds.
• GLP-Squared — a combination protocol positioned at the top of the menu.

Two honest caveats about those numbers. First, every tier is quoted as a "starts at" or "from" price, so the figure you see is the floor — as your dose climbs, expect the monthly cost to climb with it. PlexusDx doesn't publish a full per-dose price list, so confirm what your specific dose will run before you commit. Second, the tirzepatide tier, starting in the mid-two-hundreds, sits above the cheapest budget rivals; PlexusDx wins on the microdose and semaglutide tiers more than on tirzepatide. For context, the category median monthly price across the providers we track is $170.

The platform accepts HSA/FSA dollars, which softens the out-of-pocket sting. It does not accept insurance, so every dollar is cash (or pre-tax health-account funds).

The medications: compounded only, pharmacies unnamed

This is a compounded-medication program end to end. There are no FDA-approved brand-name options here — no Wegovy, no Zepbound, no Ozempic. PlexusDx says an independent, US-licensed clinician reviews your intake through a state-licensed telehealth platform and writes a prescription if you qualify, after which a state-licensed pharmacy compounds and ships your medication, with ongoing provider check-ins included.

The gap worth flagging: PlexusDx does not name the specific compounding pharmacies it uses. Plenty of telehealth brands work this way, but naming the pharmacy (and its accreditation) is a transparency signal we like to see, and its absence is the main reason our confidence in the operation lands at medium rather than high. On the plus side, there are no FDA warning letters on file against PlexusDx, and the 50-state licensed-provider claim is a genuine strength for anyone outside the big metro markets.

The genetics angle: interesting, optional, not essential

PlexusDx's real differentiator is the Precision Peptide genetic test — a panel of 151 insights that the company offers at a steep discount, dropping a near-three-hundred-dollar retail price to under a hundred dollars after your first medication order. It's a clever hook and a legitimate point of difference from every other compounded-GLP-1 brand we review.

Be clear-eyed about what it is, though. The test is a paid add-on, not something bundled into your program, and the science linking consumer genetic panels to better GLP-1 dosing decisions is thin. For many patients it'll be an interesting curiosity rather than a clinical game-changer. If the personalization story is what's drawing you to PlexusDx, treat it as a nice-to-have on top of a solid medication program — not a reason on its own to choose this provider.

Who should pick PlexusDx — and who should skip it

Choose PlexusDx if you want a low-cost, all-inclusive entry into GLP-1 therapy without insurance hassle, you live anywhere in the US, and the genetics layer appeals to you. The microdose tier at $129 a month is one of the friendlier on-ramps we've seen, and bundling the consult into the price keeps the math simple.

Skip it if you specifically want brand-name medication, if pharmacy transparency is a dealbreaker for you, or if you're shopping tirzepatide purely on price — the cheapest tirzepatide programs we track undercut PlexusDx's starting rate. You can see how we weigh price, transparency, and oversight on our scoring methodology page.

Bottom line

PlexusDx is a credible, nationwide compounded-GLP-1 program with a genuinely low entry price and a distinctive (if oversold) genetic-testing twist. The medication offering is solid and the all-inclusive pricing is refreshingly honest about what's bundled. The two things holding it back from a top-tier rating are the unnamed compounding pharmacies and the "starts at" pricing that can creep upward as your dose increases. Go in for the affordable microdose or semaglutide tiers, treat the DNA panel as optional, and confirm your exact per-dose cost before you sign up.

Worth pricing against Oak ($119/month) and HealthRX ($133/month) before you commit — both sit close to PlexusDx on cost and formulation.